Wall Street and global equity markets pushed to fresh record highs as a wave of upbeat corporate forecasts boosted investor confidence across major indices. Strong earnings guidance from a range of companies
Chip Parkinson, CEO of Gifthealth, says specialty medicine represents the clearest opportunity for direct-to-patient models to prove their value at scale. Specialty drugs already account for more than half of all drug
More
Even if the Senate moves to reject Todd Blanche, he is expected to remain in his position indefinitely, raising serious constitutional questions about the arrangement. The situation highlights growing tensions between the
More
The FTSE 100 currently yields 3%, which may look appealing compared to leading US indices but still falls short of what many investors are seeking. The FTSE 250 offers a marginally better
More
FTSE 250 dividend stocks continue to attract income-focused investors seeking reliable returns outside of traditional savings accounts in 2026. The FTSE 250 index, which tracks mid-cap UK-listed companies, has long been regarded
More
Legend Biotech has confirmed that chief executive Ying Huang, Ph.D., has stepped down after six years leading the company. Alan Bash, who has served as president of Carvykti since 2024, will take
More
The legal world’s most talked-about scandal refuses to die down, with fresh allegations emerging about senior partners at Wachtell Lipton Rosen & Katz. A viral video earlier this month showed a Wachtell
More
SLB N.V., listed on the New York Stock Exchange under the ticker SLB, has reported its second-quarter earnings, drawing fresh scrutiny from market analysts tracking the oilfield services giant. The results have
More
The FTSE 100 index ended the week fractionally below a significant milestone, capping off a period of robust performance for London’s premier stock market benchmark. The index came tantalisingly close to breaching
More
Novo Nordisk has filed a lawsuit against rival Eli Lilly (LLY), accusing the US drugmaker of running “false and misleading” advertisements for its obesity drug Zepbound. The legal clash between two of
More
A major legal divide has emerged between two Texas federal district courts over how to handle unconstitutional National Labor Relations Board removal protections. The central question is whether courts can sever the
More